China's assisted reproductive technology has developed rapidly, and the clinical pregnancy success rate of IVF has reached internationally leading levels. For families facing fertility difficulties and international patients seeking high-quality assisted reproduction services, China's technological maturity and cost-effectiveness are highly attractive.
Technological maturity and success rates
Clinical data released by reproductive medicine centers show that the clinical pregnancy rate per embryo transfer for women under 35 can reach 50%-60%, comparable to or higher than major centers in Europe and the US. The application of third-generation IVF technology (preimplantation genetic testing, PGT) enables screening of embryos for genetic diseases and chromosomal abnormalities, reducing the risk of birth defects.
Main services
These include: in vitro fertilization and embryo transfer (IVF-ET), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), frozen-thawed embryo transfer, oocyte/sperm cryopreservation, and immunotherapy for recurrent miscarriage.
Information for international patients
Under Chinese law, assisted reproduction requires a legal marriage. International patients need to provide valid identification and undergo evaluation at regulated reproductive centers. Patients are advised to prepare previous medical records and examination reports so doctors can develop personalized plans.
MedBridge assistance
MedBridge can connect international patients with renowned reproductive medicine centers in Shanghai, providing hospital selection, booking, interpretation accompaniment, cycle management and follow-up, making the journey to parenthood more reassuring.